Transgenomic Price to Free Cash Flow Ratio 2010-2023 | PRPO
Historical price to free cash flow ratio values for Transgenomic (PRPO) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Transgenomic Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-05-02 |
5.95 |
|
0.00 |
| 2023-12-31 |
6.50 |
$-2.84 |
0.00 |
| 2023-09-30 |
5.61 |
$-4.06 |
0.00 |
| 2023-06-30 |
7.80 |
$-5.76 |
0.00 |
| 2023-03-31 |
13.28 |
$-6.34 |
0.00 |
| 2022-12-31 |
11.03 |
$-7.03 |
0.00 |
| 2022-09-30 |
16.08 |
$-7.47 |
0.00 |
| 2022-06-30 |
21.20 |
$-7.31 |
0.00 |
| 2022-03-31 |
27.00 |
$-7.33 |
0.00 |
| 2021-12-31 |
31.60 |
$-6.88 |
0.00 |
| 2021-09-30 |
56.40 |
$-6.66 |
0.00 |
| 2021-06-30 |
72.60 |
$-6.02 |
0.00 |
| 2021-03-31 |
46.20 |
$-6.90 |
0.00 |
| 2020-12-31 |
41.40 |
$-9.14 |
0.00 |
| 2020-09-30 |
49.00 |
$-17.06 |
0.00 |
| 2020-06-30 |
28.40 |
$-21.20 |
0.00 |
| 2020-03-31 |
14.00 |
$-25.21 |
0.00 |
| 2019-12-31 |
41.00 |
$-32.29 |
0.00 |
| 2019-09-30 |
52.20 |
$-54.96 |
0.00 |
| 2019-06-30 |
67.60 |
$-59.62 |
0.00 |
| 2019-03-31 |
37.50 |
$-78.58 |
0.00 |
| 2018-12-31 |
46.20 |
$-95.09 |
0.00 |
| 2018-09-30 |
118.56 |
$-323.76 |
0.00 |
| 2018-06-30 |
110.34 |
$-492.97 |
0.00 |
| 2018-03-31 |
161.16 |
$-468.38 |
0.00 |
| 2017-12-31 |
360.00 |
$-441.66 |
0.00 |
| 2017-09-30 |
648.00 |
$-181.56 |
0.00 |
| 2017-06-30 |
2700.00 |
$-2.86 |
0.00 |
| 2017-03-31 |
6030.00 |
$857.94 |
7.03 |
| 2016-12-31 |
2557.80 |
$-2.22 |
0.00 |
| 2016-09-30 |
2538.00 |
$-1.79 |
0.00 |
| 2016-06-30 |
4950.00 |
$-1.42 |
0.00 |
| 2016-03-31 |
5252.40 |
$-861.53 |
0.00 |
| 2015-12-31 |
9630.00 |
$-1.02 |
0.00 |
| 2015-09-30 |
8308.80 |
$-1.01 |
0.00 |
| 2015-06-30 |
15030.00 |
$-1.36 |
0.00 |
| 2015-03-31 |
12960.00 |
$-1.69 |
0.00 |
| 2014-12-31 |
18090.00 |
$-1.85 |
0.00 |
| 2014-09-30 |
33930.00 |
$-1.86 |
0.00 |
| 2014-06-30 |
33660.00 |
$-1.43 |
0.00 |
| 2014-03-31 |
41220.00 |
$-1.29 |
0.00 |
| 2013-12-31 |
49680.00 |
$-1.25 |
0.00 |
| 2013-09-30 |
41040.00 |
$-2.73 |
0.00 |
| 2013-06-30 |
43200.00 |
$-2.66 |
0.00 |
| 2013-03-31 |
43200.00 |
$-2.36 |
0.00 |
| 2012-12-31 |
65880.00 |
$-1.91 |
0.00 |
| 2012-09-30 |
102599.99 |
$-0.10 |
0.00 |
| 2012-06-30 |
97200.00 |
$-0.08 |
0.00 |
| 2012-03-31 |
129599.99 |
$-0.05 |
0.00 |
| 2011-12-31 |
139319.99 |
$-0.00 |
0.00 |
| 2011-09-30 |
139319.99 |
$-0.04 |
0.00 |
| 2011-06-30 |
188999.99 |
$-0.04 |
0.00 |
| 2011-03-31 |
95040.00 |
$-0.05 |
0.00 |
| 2010-12-31 |
71280.00 |
$-0.04 |
0.00 |
| 2010-09-30 |
43200.00 |
$-0.00 |
0.00 |
| 2010-06-30 |
52920.00 |
$0.02 |
3226829.11 |
| 2010-03-31 |
92880.00 |
$0.02 |
3902520.82 |
| 2009-12-31 |
74520.00 |
$0.02 |
4006451.41 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.008B |
$0.015B |
|
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|
